Complement factor H in AMD: Bridging genetic associations and pathobiology

Christopher B. Toomey, Lincoln V. Johnson, Catherine Bowes Rickman

Research output: Contribution to journalReview articlepeer-review

47 Scopus citations


Age-Related Macular Degeneration (AMD) is a complex multifactorial disease characterized in its early stages by lipoprotein accumulations in Bruch's Membrane (BrM), seen on fundoscopic exam as drusen, and in its late forms by neovascularization (“wet”) or geographic atrophy of the Retinal Pigmented Epithelial (RPE) cell layer (“dry”). Genetic studies have strongly supported a relationship between the alternative complement cascade, in particular the common H402 variant in Complement Factor H (CFH) and development of AMD. However, the functional significance of the CFH Y402H polymorphism remains elusive. In this article, we critically review the literature surrounding the functional significance of this polymorphism. Furthermore, based on our group's studies we propose a model in which CFH H402 affects CFH binding to heparan sulfate proteoglycans leading to accelerated lipoprotein accumulation in BrM and drusen progression. We also review the literature on the role of other complement components in AMD pathobiologies, including C3a, C5a and the membrane attack complex (MAC), and on transgenic mouse models developed to interrogate in vivo the effects of the CFH Y402H polymorphism.

Original languageEnglish (US)
Pages (from-to)38-57
Number of pages20
JournalProgress in Retinal and Eye Research
StatePublished - Jan 2018
Externally publishedYes

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems


Dive into the research topics of 'Complement factor H in AMD: Bridging genetic associations and pathobiology'. Together they form a unique fingerprint.

Cite this